Table 2.
Multivariate regressions comparing self-reported drug use intent at pre- and posttest and Living the Example receptivity (matched participants, n=80).
| Self-reported drug use intent, exponentiated coefficient (P) | ||||||||||||||
| 1a | 2b | 3c | 4d | 5e | 6f | 7g | 8h | 9i | 10j | 11k | 12l | 13m | 14n | |
| Any LTEo exposure | 0.918 (.94) |
0.565 (.61) |
2.445 (.18) |
0.678 (.74) |
1.491 (.61) |
0.972 (.96) |
1.217 (.86) |
2.097 (.45) |
2.097 (.45) |
2.097 (.45) |
2.364 (.38) |
2.097 (.45) |
2.360 (.24) |
2.121 (.19) |
| Change from baseline to follow-up | 1.672 (.35) |
1.892 (.06) |
1.886 (.07) |
2.261 (.08) |
1.848 (.17) |
2.134 (.02) |
1.681 (.15) |
1.066 (.90) |
1.066 (.90) |
1.066 (.90) |
0.855 (.76) |
1.066 (.90) | 0.676 (.45) |
2.141 (.02) |
| Change from baseline to follow-up among those with LTE receptivity | 1.820 (.54) |
1.495 (.62) |
0.210 (.02) |
1.409 (.72) |
0.432 (.33) |
0.239 (.008) |
1.809 (.35) |
1.000 (>.99) |
1.000 (>.99) |
1.000 (>.99) |
1.000 (>.99) |
1.000 (>.99) |
0.736 (.73) |
0.111 (.004) |
| Genderp | 0.663 (.63) |
3.027 (.12) |
1.343 (.60) |
0.845 (.81) |
1.197 (.76) |
1.698 (.40) |
1.279 (.77) |
1.108 (.91) |
1.108 (.90) |
1.108 (.91) |
1.699 (.54) |
1.108 (.91) |
1.691 (.43) |
2.006 (.12) |
| Age | 0.467 (.28) |
0.560 (.24) |
0.614 (.29) |
0.428 (.17) |
0.508 (.22) |
0.834 (.70) |
0.462 (.12) |
0.782 (.74) |
0.782 (.74) |
0.782 (.74) |
0.581 (.44) |
0.782 (.74) |
0.740 (.60) |
0.673 (.33) |
aWill smoke cigarettes.
bWill use electronic cigarettes (ie, vaping).
cWill use sedatives such as sleeping pills.
dWill use tranquilizers or antianxiety drugs.
eWill use painkillers such as OxyContin or similar.
fWill use marijuana.
gWill use synthetic marijuana or K2/Spice.
hWill use cocaine.
iWill use crack.
jWill use hallucinogens.
kWill use any inhalant for kicks or to get high.
lWill use heroin.
mWill use any other medicines or substances.
nWill use at least one drug.
oLTE: Living the Example.
pFemale is the reference for gender.